Current understanding of the molecular mechanisms in Parkinson's disease: Targets for potential treatments

P Maiti, J Manna, GL Dunbar - Translational neurodegeneration, 2017 - Springer
Gradual degeneration and loss of dopaminergic neurons in the substantia nigra, pars
compacta and subsequent reduction of dopamine levels in striatum are associated with …

Emerging therapies in Parkinson disease—repurposed drugs and new approaches

A Elkouzi, V Vedam-Mai, RS Eisinger… - Nature Reviews …, 2019 - nature.com
Parkinson disease (PD) treatment options have conventionally focused on dopamine
replacement and provision of symptomatic relief. Current treatments cause undesirable …

Pathophysiology of motor dysfunction in Parkinson's disease as the rationale for drug treatment and rehabilitation

F Magrinelli, A Picelli, P Tocco, A Federico… - Parkinson's …, 2016 - Wiley Online Library
Cardinal motor features of Parkinson's disease (PD) include bradykinesia, rest tremor, and
rigidity, which appear in the early stages of the disease and largely depend on …

Parkinson disease subtypes

MA Thenganatt, J Jankovic - JAMA neurology, 2014 - jamanetwork.com
Importance It is increasingly evident that Parkinson disease (PD) is not a single entity but
rather a heterogeneous neurodegenerative disorder. Objective To evaluate available …

Cerebral causes and consequences of parkinsonian resting tremor: a tale of two circuits?

RC Helmich, M Hallett, G Deuschl, I Toni, BR Bloem - Brain, 2012 - academic.oup.com
Tremor in Parkinson's disease has several mysterious features. Clinically, tremor is seen in
only three out of four patients with Parkinson's disease, and tremor-dominant patients …

The prominent role of serotonergic degeneration in apathy, anxiety and depression in de novo Parkinson's disease

A Maillet, P Krack, E Lhommée, E Météreau, H Klinger… - Brain, 2016 - academic.oup.com
Abstract See Schrag and Politis (doi: 10.1093/aww190) for a scientific commentary on this
article. Apathy, which can occur separately or in combination with depression and anxiety, is …

Serotonin in Parkinson's disease

M Politis, F Niccolini - Behavioural brain research, 2015 - Elsevier
Parkinson's disease is a chronic neurodegenerative disorder characterized by the motor
symptoms of bradykinesia, tremor, rigidity and postural instability. However, non-motor …

The role of neuroimaging in Parkinson's disease

NSR Bidesi, I Vang Andersen… - Journal of …, 2021 - Wiley Online Library
Parkinson's disease (PD) is a neurodegenerative disorder that affects millions of people
worldwide. Two hallmarks of PD are the accumulation of alpha‐synuclein and the loss of …

Neuroimaging in Parkinson disease: from research setting to clinical practice

M Politis - Nature Reviews Neurology, 2014 - nature.com
Over the past three decades, neuroimaging studies—including structural, functional and
molecular modalities—have provided invaluable insights into the mechanisms underlying …

Effects of acute cannabidiol administration on anxiety and tremors induced by a Simulated Public Speaking Test in patients with Parkinson's disease

SM De Faria, D de Morais Fabrício… - Journal of …, 2020 - journals.sagepub.com
Background: Cannabidiol (CBD) is one of the main components of Cannabis sativa and has
anxiolytic properties, but no study has been conducted to evaluate the effects of CBD on …